BEUDAMED
    8 results · 26ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    23andMe Personal Genome Service (PGS) Pharmacogenetic Reports

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    MUTYH-Associated Polyposis (MAP)

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    23andMe Personal Genome Service (PGS) Pharmacogenetic Reports

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    23andMe Personal Genome Service (PGS) Pharmacogenetic Reports

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    23andMe® Personal Genome Service® (PGS®) Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)

    FDA 510(k)
    FDA Class 2 ·Medical Genetics

    23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia

    FDA 510(k)
    FDA Class 2 ·Immunology

    23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)

    FDA 510(k)
    FDA Class 2 ·Medical Genetics